Dr. Julie Gerberding Speaking Fee: $20,000 to $30,000
Speaking Fee:
$20,000 to $30,000
Travels From:
PHL - Philadelphia, PA
Travels From:
PHL - Philadelphia, PA
Primary Topic Category:
Healthcare
Primary Topic Category:
Healthcare
Secondary Topic Category:
Leadership and Management
Secondary Topic Category:
Leadership and Management
Dr. Julie Gerberding Speaker Profile: At A Glance
From her days as a young scientist at the UCSF while AIDS unfolded to her 6.5 years as the first woman director of the Centers for Disease Control and Prevention (CDC), Dr. Julie Gerberding has provided effective leadership and a calming voice to the public during more than 40 public health emergencies—including the anthrax attacks of 2001, SARS, and avian influenza. Dr. Julie is the CEO of the Foundation for the National Institutes of Health (FNIH), which creates and manages research alliances with public and private institutions in support of the mission of the NIH to enhance health, lengthen life, and reduce illness and disability.
Dr. Julie Gerberding is a distinguished leader in public health and healthcare, known for her groundbreaking work in infectious disease prevention and global health security. She currently serves as the CEO of the Foundation for the National Institutes of Health (FNIH), where she spearheads initiatives to enhance patient outcomes and advance medical research. Prior to this role, Dr. Gerberding made history as the first woman to direct the U.S. Centers for Disease Control and Prevention (CDC), guiding the agency through major public health emergencies including the anthrax attacks, SARS, and avian influenza.
During her tenure at the CDC, Dr. Gerberding was instrumental in managing over 40 domestic and international health crises, demonstrating exceptional leadership and strategic vision. Her efforts were pivotal in shaping the agency’s response to emerging health threats and improving its global reach. Following her impactful career at the CDC, she joined Merck & Co., Inc., where she held several executive roles, including Chief Patient Officer and Executive Vice President, Population Health & Sustainability. At Merck, she focused on patient engagement, corporate social responsibility, and enhancing global access to vaccines.
Dr. Gerberding's contributions extend beyond her executive roles. She is a renowned advocate for health system transformation and resilience, emphasizing the importance of prevention, preparedness, and sustainable health practices. Her work has earned her numerous accolades, including being named one of Time Magazine’s “100 Most Influential People in the World” and Forbes’ “100 Most Powerful Women in the World.” Her commitment to improving public health is reflected in her involvement with various global health organizations and advisory boards.
As a sought-after keynote speaker, Dr. Gerberding shares her wealth of knowledge and experience with diverse audiences, inspiring leaders in healthcare, business, and policy to prioritize health and resilience. Her compelling insights and evidence-based approaches continue to influence public health strategies and drive positive change in communities worldwide.